| UniProt ID | CAC1H_HUMAN | |
|---|---|---|
| UniProt AC | O95180 | |
| Protein Name | Voltage-dependent T-type calcium channel subunit alpha-1H | |
| Gene Name | CACNA1H | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 2353 | |
| Subcellular Localization |
Cell membrane Multi-pass membrane protein . Interaction with STAC increases expression at the cell membrane. |
|
| Protein Description | Voltage-sensitive calcium channel that gives rise to T-type calcium currents. T-type calcium channels belong to the "low-voltage activated (LVA)" group. A particularity of this type of channel is an opening at quite negative potentials, and a voltage-dependent inactivation. [PubMed: 9670923] | |
| Protein Sequence | MTEGARAADEVRVPLGAPPPGPAALVGASPESPGAPGREAERGSELGVSPSESPAAERGAELGADEEQRVPYPALAATVFFCLGQTTRPRSWCLRLVCNPWFEHVSMLVIMLNCVTLGMFRPCEDVECGSERCNILEAFDAFIFAFFAVEMVIKMVALGLFGQKCYLGDTWNRLDFFIVVAGMMEYSLDGHNVSLSAIRTVRVLRPLRAINRVPSMRILVTLLLDTLPMLGNVLLLCFFVFFIFGIVGVQLWAGLLRNRCFLDSAFVRNNNLTFLRPYYQTEEGEENPFICSSRRDNGMQKCSHIPGRRELRMPCTLGWEAYTQPQAEGVGAARNACINWNQYYNVCRSGDSNPHNGAINFDNIGYAWIAIFQVITLEGWVDIMYYVMDAHSFYNFIYFILLIIVGSFFMINLCLVVIATQFSETKQRESQLMREQRARHLSNDSTLASFSEPGSCYEELLKYVGHIFRKVKRRSLRLYARWQSRWRKKVDPSAVQGQGPGHRQRRAGRHTASVHHLVYHHHHHHHHHYHFSHGSPRRPGPEPGACDTRLVRAGAPPSPPSPGRGPPDAESVHSIYHADCHIEGPQERARVAHAAATAAASLRLATGLGTMNYPTILPSGVGSGKGSTSPGPKGKWAGGPPGTGGHGPLSLNSPDPYEKIPHVVGEHGLGQAPGHLSGLSVPCPLPSPPAGTLTCELKSCPYCTRALEDPEGELSGSESGDSDGRGVYEFTQDVRHGDRWDPTRPPRATDTPGPGPGSPQRRAQQRAAPGEPGWMGRLWVTFSGKLRRIVDSKYFSRGIMMAILVNTLSMGVEYHEQPEELTNALEISNIVFTSMFALEMLLKLLACGPLGYIRNPYNIFDGIIVVISVWEIVGQADGGLSVLRTFRLLRVLKLVRFLPALRRQLVVLVKTMDNVATFCTLLMLFIFIFSILGMHLFGCKFSLKTDTGDTVPDRKNFDSLLWAIVTVFQILTQEDWNVVLYNGMASTSSWAALYFVALMTFGNYVLFNLLVAILVEGFQAEGDANRSDTDEDKTSVHFEEDFHKLRELQTTELKMCSLAVTPNGHLEGRGSLSPPLIMCTAATPMPTPKSSPFLDAAPSLPDSRRGSSSSGDPPLGDQKPPASLRSSPCAPWGPSGAWSSRRSSWSSLGRAPSLKRRGQCGERESLLSGEGKGSTDDEAEDGRAAPGPRATPLRRAESLDPRPLRPAALPPTKCRDRDGQVVALPSDFFLRIDSHREDAAELDDDSEDSCCLRLHKVLEPYKPQWCRSREAWALYLFSPQNRFRVSCQKVITHKMFDHVVLVFIFLNCVTIALERPDIDPGSTERVFLSVSNYIFTAIFVAEMMVKVVALGLLSGEHAYLQSSWNLLDGLLVLVSLVDIVVAMASAGGAKILGVLRVLRLLRTLRPLRVISRAPGLKLVVETLISSLRPIGNIVLICCAFFIIFGILGVQLFKGKFYYCEGPDTRNISTKAQCRAAHYRWVRRKYNFDNLGQALMSLFVLSSKDGWVNIMYDGLDAVGVDQQPVQNHNPWMLLYFISFLLIVSFFVLNMFVGVVVENFHKCRQHQEAEEARRREEKRLRRLERRRRSTFPSPEAQRRPYYADYSPTRRSIHSLCTSHYLDLFITFIICVNVITMSMEHYNQPKSLDEALKYCNYVFTIVFVFEAALKLVAFGFRRFFKDRWNQLDLAIVLLSLMGITLEEIEMSAALPINPTIIRIMRVLRIARVLKLLKMATGMRALLDTVVQALPQVGNLGLLFMLLFFIYAALGVELFGRLECSEDNPCEGLSRHATFSNFGMAFLTLFRVSTGDNWNGIMKDTLRECSREDKHCLSYLPALSPVYFVTFVLVAQFVLVNVVVAVLMKHLEESNKEAREDAELDAEIELEMAQGPGSARRVDADRPPLPQESPGARDAPNLVARKVSVSRMLSLPNDSYMFRPVVPASAPHPRPLQEVEMETYGAGTPLGSVASVHSPPAESCASLQIPLAVSSPARSGEPLHALSPRGTARSPSLSRLLCRQEAVHTDSLEGKIDSPRDTLDPAEPGEKTPVRPVTQGGSLQSPPRSPRPASVRTRKHTFGQRCVSSRPAAPGGEEAEASDPADEEVSHITSSACPWQPTAEPHGPEASPVAGGERDLRRLYSVDAQGFLDKPGRADEQWRPSAELGSGEPGEAKAWGPEAEPALGARRKKKMSPPCISVEPPAEDEGSARPSAAEGGSTTLRRRTPSCEATPHRDSLEPTEGSGAGGDPAAKGERWGQASCRAEHLTVPSFAFEPLDLGVPSGDPFLDGSHSVTPESRASSSGAIVPLEPPESEPPMPVGDPPEKRRGLYLTVPQCPLEKPGSPSATPAPGGGADDPV | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 49 | Phosphorylation | RGSELGVSPSESPAA CCCCCCCCCCCCHHH | 22.40 | 27732954 | |
| 51 | Phosphorylation | SELGVSPSESPAAER CCCCCCCCCCHHHHH | 43.11 | 27732954 | |
| 53 | Phosphorylation | LGVSPSESPAAERGA CCCCCCCCHHHHHCC | 24.95 | 27732954 | |
| 170 | Phosphorylation | QKCYLGDTWNRLDFF CCCCCCCCCCCCCEE | 23.88 | 29052541 | |
| 192 | N-linked_Glycosylation | EYSLDGHNVSLSAIR EECCCCCCCCHHHHH | 30.51 | UniProtKB CARBOHYD | |
| 215 | Phosphorylation | RAINRVPSMRILVTL HHHCCCCCHHHHHHH | 20.17 | 22617229 | |
| 271 | N-linked_Glycosylation | SAFVRNNNLTFLRPY HHHHCCCCEEEEEEE | 43.96 | UniProtKB CARBOHYD | |
| 343 | Phosphorylation | ACINWNQYYNVCRSG HCCCHHHHHCCCCCC | 8.19 | 29759185 | |
| 344 | Phosphorylation | CINWNQYYNVCRSGD CCCHHHHHCCCCCCC | 7.43 | 29759185 | |
| 394 | Phosphorylation | VMDAHSFYNFIYFIL HHHHHHHHHHHHHHH | 16.51 | 26074081 | |
| 398 | Phosphorylation | HSFYNFIYFILLIIV HHHHHHHHHHHHHHH | 4.76 | 26074081 | |
| 446 | Phosphorylation | RHLSNDSTLASFSEP HHCCCCCCCHHHCCC | 29.25 | - | |
| 475 | Phosphorylation | FRKVKRRSLRLYARW HHHHHHHHHHHHHHH | 23.13 | 29449344 | |
| 479 | Phosphorylation | KRRSLRLYARWQSRW HHHHHHHHHHHHHHH | 6.41 | 29449344 | |
| 484 | Phosphorylation | RLYARWQSRWRKKVD HHHHHHHHHHHHCCC | 27.18 | 29449344 | |
| 558 | Phosphorylation | VRAGAPPSPPSPGRG EECCCCCCCCCCCCC | 48.67 | 23312004 | |
| 561 | Phosphorylation | GAPPSPPSPGRGPPD CCCCCCCCCCCCCCC | 43.29 | 23312004 | |
| 615 | Phosphorylation | LGTMNYPTILPSGVG CCCCCCCCCCCCCCC | 25.45 | - | |
| 619 | Phosphorylation | NYPTILPSGVGSGKG CCCCCCCCCCCCCCC | 42.54 | - | |
| 623 | Phosphorylation | ILPSGVGSGKGSTSP CCCCCCCCCCCCCCC | 34.62 | - | |
| 749 | Phosphorylation | PTRPPRATDTPGPGP CCCCCCCCCCCCCCC | 41.50 | 29691806 | |
| 751 | Phosphorylation | RPPRATDTPGPGPGS CCCCCCCCCCCCCCC | 26.28 | 29691806 | |
| 758 | Phosphorylation | TPGPGPGSPQRRAQQ CCCCCCCCHHHHHHH | 22.46 | 30266825 | |
| 783 | Phosphorylation | GRLWVTFSGKLRRIV EEEEEEECCHHHHHH | 26.17 | 18187866 | |
| 881 | Phosphorylation | GQADGGLSVLRTFRL CCCCCCHHHHHHHHH | 23.52 | 24719451 | |
| 1044 | Ubiquitination | HFEEDFHKLRELQTT CHHHHHHHHHHHHCC | 49.59 | - | |
| 1071 | Phosphorylation | GHLEGRGSLSPPLIM CCCCCCCCCCCCEEE | 25.06 | 27251275 | |
| 1073 | Phosphorylation | LEGRGSLSPPLIMCT CCCCCCCCCCEEEEE | 26.60 | 28348404 | |
| 1090 | Phosphorylation | TPMPTPKSSPFLDAA CCCCCCCCCCCHHCC | 44.43 | 29449344 | |
| 1091 | Phosphorylation | PMPTPKSSPFLDAAP CCCCCCCCCCHHCCC | 26.29 | 29449344 | |
| 1099 | Phosphorylation | PFLDAAPSLPDSRRG CCHHCCCCCCCCCCC | 48.05 | 27732954 | |
| 1103 | Phosphorylation | AAPSLPDSRRGSSSS CCCCCCCCCCCCCCC | 23.18 | 27732954 | |
| 1107 | Phosphorylation | LPDSRRGSSSSGDPP CCCCCCCCCCCCCCC | 25.82 | 19131331 | |
| 1108 | Phosphorylation | PDSRRGSSSSGDPPL CCCCCCCCCCCCCCC | 31.20 | 28348404 | |
| 1109 | Phosphorylation | DSRRGSSSSGDPPLG CCCCCCCCCCCCCCC | 39.78 | 28348404 | |
| 1110 | Phosphorylation | SRRGSSSSGDPPLGD CCCCCCCCCCCCCCC | 49.52 | 28348404 | |
| 1143 | Phosphorylation | GAWSSRRSSWSSLGR CCCCCCCCCCHHCCC | 34.74 | 28348404 | |
| 1144 | Phosphorylation | AWSSRRSSWSSLGRA CCCCCCCCCHHCCCC | 29.21 | 28348404 | |
| 1168 | Phosphorylation | GERESLLSGEGKGST CCCCCCCCCCCCCCC | 39.84 | 30278072 | |
| 1174 | Phosphorylation | LSGEGKGSTDDEAED CCCCCCCCCCCCCCC | 31.95 | 30278072 | |
| 1175 | Phosphorylation | SGEGKGSTDDEAEDG CCCCCCCCCCCCCCC | 57.02 | 30278072 | |
| 1191 | Phosphorylation | AAPGPRATPLRRAES CCCCCCCCCCCCHHH | 24.92 | 17081983 | |
| 1198 | Phosphorylation | TPLRRAESLDPRPLR CCCCCHHHCCCCCCC | 36.77 | 16917542 | |
| 1275 | Phosphorylation | SREAWALYLFSPQNR CCCCHHHHHCCCCCC | 9.65 | 29083192 | |
| 1278 | Phosphorylation | AWALYLFSPQNRFRV CHHHHHCCCCCCEEE | 23.99 | 29083192 | |
| 1425 | Phosphorylation | LVVETLISSLRPIGN HHHHHHHHHCCCHHH | 26.82 | 24719451 | |
| 1426 | Phosphorylation | VVETLISSLRPIGNI HHHHHHHHCCCHHHH | 22.77 | 25954137 | |
| 1466 | N-linked_Glycosylation | CEGPDTRNISTKAQC EECCCCCCCCHHHHH | 34.35 | UniProtKB CARBOHYD | |
| 1587 | Phosphorylation | RLERRRRSTFPSPEA HHHHHHHCCCCCHHH | 32.37 | 24719451 | |
| 1805 | Phosphorylation | FLTLFRVSTGDNWNG HHHEEECCCCCCCCH | 23.55 | 26552605 | |
| 1806 | Phosphorylation | LTLFRVSTGDNWNGI HHEEECCCCCCCCHH | 45.77 | 26552605 | |
| 1817 | Phosphorylation | WNGIMKDTLRECSRE CCHHHHHHHHHHCCC | 23.38 | 26552605 | |
| 1822 | Phosphorylation | KDTLRECSREDKHCL HHHHHHHCCCCHHHH | 33.67 | 26552605 | |
| 1890 | Phosphorylation | EMAQGPGSARRVDAD EECCCCCCCCCCCCC | 23.03 | 29523821 | |
| 1905 | Phosphorylation | RPPLPQESPGARDAP CCCCCCCCCCCCCCC | 24.32 | 28555341 | |
| 1920 | Phosphorylation | NLVARKVSVSRMLSL CCCCCCCCHHHHHCC | 19.87 | 27282143 | |
| 1926 | Phosphorylation | VSVSRMLSLPNDSYM CCHHHHHCCCCCCCC | 32.22 | 28348404 | |
| 1991 | Phosphorylation | AVSSPARSGEPLHAL EECCCCCCCCCCCCC | 50.00 | - | |
| 1999 | Phosphorylation | GEPLHALSPRGTARS CCCCCCCCCCCCCCC | 17.21 | 24719451 | |
| 2057 | Phosphorylation | TQGGSLQSPPRSPRP CCCCCCCCCCCCCCC | 42.01 | 27732954 | |
| 2073 | Phosphorylation | SVRTRKHTFGQRCVS CCCCCCCCCCCCCCC | 32.28 | - | |
| 2136 | Phosphorylation | ERDLRRLYSVDAQGF CCCHHHHHEECCCCC | 12.58 | 23312004 | |
| 2137 | Phosphorylation | RDLRRLYSVDAQGFL CCHHHHHEECCCCCC | 20.36 | 28348404 | |
| 2188 | Phosphorylation | ARRKKKMSPPCISVE CCCCCCCCCCCEECC | 34.27 | - |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CAC1H_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CAC1H_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| KLHL1_HUMAN | KLHL1 | physical | 20147652 | |
| UBP5_HUMAN | USP5 | physical | 25889575 |
| Kegg Disease | |
|---|---|
| There are no disease associations of PTM sites. | |
| OMIM Disease | |
| 611942 | Epilepsy, idiopathic generalized 6 (EIG6) |
| 611942 | Epilepsy, childhood absence 6 (ECA6) |
| Kegg Drug | |
| D00304 | Divalproex sodium (USP); Valproate semisodium (INN); Depakote (TN) |
| D00399 | Valproic acid (USP); Depakene (TN) |
| D00538 | Zonisamide (JAN/USAN/INN); Excegran (TN) |
| D00539 | Ethosuximide (JP16/USP/INN); Zarontin (TN) |
| D00631 | Bepridil hydrochloride hydrate (JAN); Bepridil hydrochloride (USAN); Vascor (TN) |
| D00710 | Sodium valproate (JP16); Valproate sodium (USAN); Depakene (TN); Selenica (TN) |
| D01303 | Flunarizine hydrochloride (JAN/USAN) |
| D01562 | Aranidipine (JAN/INN); Sapresta (TN) |
| D01604 | Efonidipine hydrochloride ethanolate (JAN); Efonidipine hydrochloride ethanol; Efonidipine hydrochlo |
| D02630 | Penfluridol (USAN/INN); Semap (TN) |
| D05024 | Mibefradil dihydrochloride (USAN); Posicor (TN) |
| D07520 | Bepridil (INN); Bepadin (TN) |
| D07886 | Efonidipine (INN) |
| D07971 | Flunarizine (INN); Sibelium (TN) |
| D08217 | Mibefradil (INN) |
| D08667 | Calcium valproate; Valproic acid calcium salt; Convulsofin (TN) |
| DrugBank | |
| DB01118 | Amiodarone |
| DB01244 | Bepridil |
| DB00568 | Cinnarizine |
| DB01023 | Felodipine |
| DB04841 | Flunarizine |
| DB00270 | Isradipine |
| DB01115 | Nifedipine |
| DB01054 | Nitrendipine |
| DB00421 | Spironolactone |
| DB00909 | Zonisamide |
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-783, AND MASSSPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1191, AND MASSSPECTROMETRY. | |